Clinical Trial Update: Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma [Phase 2]

View source ↗

Summary

This report provides an update on a Phase 2 clinical trial of bintrafusp alfa (M7824) in patients with thymic epithelial tumors, thymoma, and thymic carcinoma. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymic Epithelial Tumor
• Thymoma

Drugs mentioned

• Bintrafusp alfa (bintrafusp alfa)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Thymic Epithelial Tumor, Recurrent Thymoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING